Citizens JMP’s $27 target on SGMT

SGMT Sagimet Biosciences

$9.37 → $27 (+188%) by Oct 2027

Market Outperform · lowers · said Oct 1, 2026 · 12-month default horizon

Open: judged on the close on Oct 1, 2027

The article this target came from

Citizens cuts Sagimet Biosciences stock price target on trial data

Investing.com · Oct 1, 2026

Citizens lowered its price target on Sagimet Biosciences Inc (NASDAQ:SGMT) to $27.00 from $29.00 while maintaining a Market Outperform rating.

Citizens JMP’s track record → Sagimet Biosciences →

A fact about what Citizens JMP published, as reported by Investing.com, not a recommendation from Dalsna Finance; Citizens JMP is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.